Keywords: nicox, fy, income, doubles, big, ahead, french
NicOx' FY 2007 income doubles, big year ahead
Article | 10 March 2008
French drug development firm NicOx SA's full-year 2007 revenues increased to 20.6 million euros ($31.3 million) from 9.6 million euros in the prior year, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
